EconPapers    
Economics at your fingertips  
 

Tracing the Weaknesses of the Regulatory Framework for Clinical Trial in Nigeria

Sani Ibrahim Salihu, Yuhanif Yusof and Rohizan Halim

Journal of Business and Social Review in Emerging Economies, 2015, vol. 1, issue 2, 77-86

Abstract: Nigeria is one of the developing countries with a very weak and incomprehensive regulatory framework for clinical trials. Past abuses of human subjects in clinical trials and cases of negligence and outright fraud necessitate the need for a stronger legal framework. An outbreak of meningitis in Nigeria in 1996 led to clinical trial of Trovan Drugs by Pfizer, which left many of the research subjects seriously impaired. Some died while some suffered paralysis and brain damage. It was obvious Nigeria has a weak regulatory frame work from the incident that took place in the mentioned above at the Infectious Dieses Hospital (IDH) Kano. Available literatures have also shown that at the time of the trial in Kano, there was no ethics committee to ensure ethics review process and monitor the ongoing trial.Objectives: This research aimed at examining the Nigerian regulatory framework to bring out its weaknesses. It will also examine the strength and weakness of the current regulatory agencies, and suggest better regulatory framework that will make Nigerians less vulnerable to manipulation and fraud in clinical trials.Methodology: Library research is used to study both primary and secondary legal resources.Finding: Lack of standard regulatory body and lack unified legal framework is the cause of failure to protect human subject in Nigeria.

Keywords: Clinical Trial; Informed Consent; Ethics; Human Rights (search for similar items in EconPapers)
Date: 2015
References: Add references at CitEc
Citations:

Downloads: (external link)
https://publishing.globalcsrc.org/ojs/index.php/jbsee/article/view/10/373 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:src:jbsree:v:1:y:2015:i:2:p:77-86

DOI: 10.26710/jbsee.v1i2.10

Access Statistics for this article

More articles in Journal of Business and Social Review in Emerging Economies from CSRC Publishing, Center for Sustainability Research and Consultancy Pakistan Contact information at EDIRC.
Bibliographic data for series maintained by Prof. Dr. Ghulam Shabir ().

 
Page updated 2025-03-20
Handle: RePEc:src:jbsree:v:1:y:2015:i:2:p:77-86